National Bank of Canada
ZYME icon

National Bank of Canada’s Zymeworks ZYME Stock Holding History

National Bank of Canada’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.9K Buy
554
+9
+2% +$213 ﹤0.01% 2255
2025
Q4 		$14.3K Sell
545
-4
-0.7% -$87 ﹤0.01% 2229
2025
Q3 		$9.37K Buy
549
+77
+16% +$1.1K ﹤0.01% 2339
2025
Q2 		$5.92K Sell
472
-52
-10% -$619 ﹤0.01% 2457
2025
Q1 		$6.24K Sell
524
-24
-4% -$327 ﹤0.01% 2340
2024
Q4 		$8.02K Sell
548
-21
-4% -$294 ﹤0.01% 2380
2024
Q3 		$7.14K Sell
569
-10
-2% -$109 ﹤0.01% 2141
2024
Q2 		$4.95K Hold
579
– – ﹤0.01% 2258
2024
Q1 		$5.1K Buy
+579
New +$6.43K ﹤0.01% 2303
2023
Q2 		– Sell
-620
Closed -$5.6K – 2842
2023
Q1 		$5.6K Buy
+620
New +$5.41K ﹤0.01% 2262
2022
Q4 		– Sell
-395,478
Closed -$2.43M – 2925
2022
Q3 		$2.43M Buy
395,478
+76,923
+24% +$464K 0.01% 735
2022
Q2 		$1.69M Hold
318,555
– – 0.01% 840
2022
Q1 		$2.09M Buy
318,555
+317,955
+52,993% +$2.83M 0.01% 861
2021
Q4 		$10K Buy
+600
New +$12.5K ﹤0.01% 2368

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

National Bank of Canada's ZYME Position: Q1 2026 in Review

National Bank of Canada increased its Zymeworks (ZYME) stake by 1.7% in Q1 2026, buying an estimated $213 and bringing the position to 554 shares worth $13.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2255.

National Bank of Canada first reported a position in ZYME in Q4 2021 and has held it in 14 quarters since. The position peaked at $2.43M in Q3 2022. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • National Bank of Canada held 554 shares of Zymeworks worth $13.9K as of Q1 2026.
  • National Bank of Canada bought 9 Zymeworks shares in Q1 2026, an estimated $213.
  • Zymeworks made up ﹤0.01% of National Bank of Canada's portfolio in Q1 2026, its #2255 holding.
  • National Bank of Canada first reported a position in Zymeworks in Q4 2021 and has held it in 14 quarters since.
  • National Bank of Canada's Zymeworks position peaked at $2.43M in Q3 2022.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.